條款及細則｜Terms and Conditions：
- 注意⚠️ 有關流感疫苗接種-符合政府資助計劃的香港居民包括 | ATTENTION!⚠️ The eligible group for HK Government Subsidy are HK Residents that fits in one of the followings:
- 50歲或以上人士 (以出生年份計算）| Persons aged 50 years or above (Count by year of birth)
- 所有6個月至17歲的兒童或：| Children 6 months to 17 years old or:
- 18歲或以上就讀於香港中學的學生|18 years old or above studying at a secondary school in Hong Kong
- 孕婦 (持有有效的醫療證明書或由已登記的私家醫生確認懷孕狀況|Pregnant women (with valid medical certificate or with pregnancy status confirmed by the attending enrolled VSS doctor)
- 18至49歲 獲證明的智障或傷殘人士｜Persons Aged 18 to 49 years with physical or intellectual disability who are holding valid certificate
- 使用此服務前必須預約｜ Advance booking is required
- 海灣醫療保留最終解釋權 ｜Marina Medical reserves the rights to the final decision concerning the offers mentioned above
---------------------------------------------------------------------------------------------
哪些人士較易患上流感？Who is at risk?
每年都有大量流感個案。部分人會有較高風險患上流感，包括長者，幼童及有健康問題的人士。
Every year many people get sick with the flu. Some groups are at higher risk than others, including the elderly, young children, and people with certain health conditions.
應該何時接種疫苗？When should get vaccinated?
較理想的接種時間為九月和十月。但只要流感病毒還在社區傳播，即使一月份或之後，大衆也應繼續接種疫苗。
September and October are good times to get vaccinated. However, as long as flu viruses are circulating, vaccination should continue, even in January or later.
有哪些疫苗種類？What are the vaccine types?
三種不同的流感疫苗類型：There are three types of influenza vaccines:
（a）滅活疫苗（注射式-流感針） Inactivated Influenza Vaccine (Flu shot);
（b）重組疫苗（注射式-流感針）Recombinant influenza vaccine (Flu shot)
（c）減活疫苗（噴鼻式）Live-attenuated Influenza Vaccine (Nasal spray)
滅活流感疫苗（流感針）在製造過程中使用已死亡的病毒配製而成；重組流感疫苗含有利用基因重組技術製造的血球凝集素（一種流感病毒表面抗原），而製作過程中不涉及蛋或流感病毒；而減活流感疫苗（噴鼻）則含有已弱化的病毒。
滅活病毒已被醫學界證實，它們在人體内只觸發有限度的反應，並不會導致受種者生病。與滅活流感疫苗相反，減活流感疫苗模擬通過鼻腔自然感染，從而產生較強和持久的免疫保護。
根據世界衛生組織（WHO）的建議，注射式和噴鼻式疫苗的成效取決於疫苗中的病毒是否與社區傳播的病毒兼容。
The inactivated influenza vaccine is formulated with the viruses that have been inactivated during the manufacturing process, the recombinant influenza vaccine contains haemagglutinin (a surface protein of influenza virus) that is produced by recombinant technology, and does not require egg or influenza virus in the production process, while the nasal spray contains viruses that are attenuated or weakened right at the beginning of the manufacturing.
The inactivated viruses are validated by the medical science that they only trigger restricted growth in the body and can hardly replicate themselves to manifest into a real illness. As opposed to the flu shot, the nasal spray simulates natural infection through the nose and may be able to induce stronger and long-lasting immune protection.
For both flu shots and nasal sprays, the effectiveness will depend on whether the virus strains in the vaccine, based on the WHO recommendation, are compatible with the virus strains circulating in the community.
